ADVB
Income statement / Annual
Last year (2023), Advanced Biomed Inc. Common Stock's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Advanced Biomed Inc. Common Stock's net income was -$2.78 M.
See Advanced Biomed Inc. Common Stock,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
Research and Development Expenses |
$880,193.00
|
$1.38 M
|
$1.62 M
|
$1.73 M
|
General & Administrative Expenses |
$1.26 M
|
$1.32 M
|
$624,774.00
|
$44,470.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$1.26 M
|
$1.32 M
|
$624,774.00
|
$44,470.00
|
Other Expenses |
$399,602.00
|
$365,231.00
|
$130,066.00
|
$57,850.00
|
Operating Expenses |
$2.54 M
|
$3.07 M
|
$2.37 M
|
$1.84 M
|
Cost And Expenses |
$2.54 M
|
$3.07 M
|
$2.37 M
|
$1.84 M
|
Interest Income |
$53,495.00
|
$21,402.00
|
$243.00
|
$28.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$399,602.00
|
$365,231.00
|
$126,632.00
|
$57,850.00
|
EBITDA |
-$2.14 M |
-$2.71 M |
-$2.24 M |
-$1.78 M |
EBITDA Ratio |
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
-$240,706.00
|
-$661,554.00
|
-$1.65 M
|
-$218.00
|
Income Before Tax |
-$2.78 M
|
-$3.73 M
|
-$4.03 M
|
-$1.84 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Net Income |
-$2.78 M
|
-$3.73 M
|
-$4.03 M
|
-$1.84 M
|
Net Income Ratio |
0
|
0
|
0
|
0
|
EPS |
-0.14 |
-0.19 |
-0.28 |
-0.16 |
EPS Diluted |
-0.14 |
-0.19 |
-0.28 |
-0.16 |
Weighted Average Shares Out |
$20.00 M
|
$19.94 M
|
$14.18 M
|
$11.46 M
|
Weighted Average Shares Out Diluted |
$20.00 M
|
$19.94 M
|
$14.18 M
|
$11.46 M
|
Link |
|
|
|
|